Updates are available Correction dated 2023-11-10
Click to view Correction: https://doi.org/10.1038/s41467-023-43057-w
-
Authors
Ayuso, Jose M. https://orcid.org/0000-0002-9414-1845
Farooqui, Mehtab
Virumbrales-Muñoz, María https://orcid.org/0000-0003-3660-8651
Denecke, Katheryn
Rehman, Shujah https://orcid.org/0000-0001-9527-743X
Schmitz, Rebecca
Guerrero, Jorge F. https://orcid.org/0000-0002-4510-5151
Sanchez-de-Diego, Cristina
Campo, Sara Abizanda
Maly, Elizabeth M.
Forsberg, Matthew H.
Kerr, Sheena C.
Striker, Robert
Sherer, Nathan M. https://orcid.org/0000-0001-9974-236X
Harari, Paul M.
Capitini, Christian M. https://orcid.org/0000-0002-2276-6731
Skala, Melissa C. https://orcid.org/0000-0002-6320-7637
Beebe, David J. https://orcid.org/0000-0002-0415-9006
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01 CA185747, R01 CA205101, R01AI110221)
U.S. Department of Health & Human Services | National Institutes of Health
National Science Foundation (CBET-1642287)
U.S. Department of Health & Human Services | National Institutes of Health
- License Information
-
More Information
Article History
Received: 4 April 2022
Accepted: 12 September 2023
First Online: 21 October 2023
Change Date: 10 November 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-023-43057-w
Competing interests
: D.J.B. has an equity interest in Tasso, Inc. D.J.B. is a stockowner of Bellbrook Labs, LLC, he is also a founder, stockowner, and manager of Salus Discovery LLC, CSO Flambeau Diagnostics LLC, stockowner of Lynx Biosciences, LLC, Onexio Biosystems, LLC, Stacks to the Future, LLC, and Turba LLC, a company developing antibiotic testing devices. The other authors declare no competing interests.
